Pengetahuan Beranda Kesehatan Manusia Pengetahuan All Opini Makalah Ilmu pengetahuan populer Wawancara Saring Therapeutic areas COVID-19 Kesehatan pencernaan Apply Beranda Kesehatan Manusia Pengetahuan Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial Beranda Kesehatan Manusia Pengetahuan Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 Beranda Kesehatan Manusia Pengetahuan Humoral immune response against XBB.1.5 and BQ.1.1 SARS-CoV-2 variants of a fourth dose of PHH-1V vaccine in adult subjects Beranda Kesehatan Manusia Pengetahuan RBDCOV Talks HIPRA’s participation: In 5 minutes, what is a recombinant protein vaccine? Beranda Kesehatan Manusia Pengetahuan RBDCOV: The project’s origins and future endeavours Beranda Kesehatan Manusia Pengetahuan Reactogenicity of third and fourth booster doses of HIPRA PHH-1V, a bivalent recombinant protein vaccine against SARS-CoV-2 Beranda Kesehatan Manusia Pengetahuan Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine in subjects previously vaccinated with a mRNA vaccine Beranda Kesehatan Manusia Pengetahuan One-year humoral response of PHH-1V booster vaccine in subjects previously vaccinated against COVID-19 with a mRNA vaccine Beranda Kesehatan Manusia Pengetahuan Dr. Àlex Soriano (Hospital Clínic de Barcelona): "Public-private collaboration is essential to achieve significant scientific advances" Muat lebih banyak
